Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Public ClinicalTrials.gov record NCT07404865. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Telitacicept in Adult Participants With Active Primary Sjögren's Disease
Study identification
- NCT ID
- NCT07404865
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Vor Biopharma
- Industry
- Enrollment
- 250 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Telitacicept Biological
Drug · Biological
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 25, 2026
- Primary completion
- Nov 30, 2028
- Completion
- Dec 31, 2028
- Last update posted
- Apr 28, 2026
2026 – 2029
United States locations
- U.S. sites
- 12
- U.S. states
- 6
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Arthritis & Rheumatology Associates, P.C. | Tucson | Arizona | 85704 | Recruiting |
| Wallace Rheumatic Study Center | Beverly Hills | California | 90210 | Recruiting |
| Finlay Medical Research Corp | Green Acres | Florida | 33467 | Recruiting |
| Chicago Clinical Research Institute Inc | Chicago | Illinois | 60607 | Recruiting |
| Willow Rheumatology & Wellness | Willowbrook | Illinois | 60527 | Recruiting |
| Accurate Clinical Research, Inc. | Lake Charles | Louisiana | 70605 | Recruiting |
| Arthritis and Rheumatology Research Institute, PLLC | Allen | Texas | 75013 | Recruiting |
| Novel Research LLC | Bellaire | Texas | 77401 | Recruiting |
| Precision Comprehensive Clinical Research Solutions | Euless | Texas | 76040 | Recruiting |
| Accurate Clinical Research, Inc. | Houston | Texas | 77089 | Recruiting |
| R&H Clinical Research Inc. | Katy | Texas | 77450 | Recruiting |
| Velocity Clinical Research, Waco | Waco | Texas | 76710 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07404865, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 28, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07404865 live on ClinicalTrials.gov.